GlobeNewsWire · ANL · October 15, 2026

Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

Get the app for more

Explore stock news, insights and company research.